{"id":"biological-fecal-microbiota-transplantation","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Abdominal pain"},{"rate":"10-20%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL6068500","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This process aims to treat various gastrointestinal disorders by introducing beneficial bacteria and other microorganisms into the patient's gut. The exact mechanisms of action are not fully understood, but it is believed to involve the restoration of a healthy gut microbiome, which can help to regulate the immune system and improve overall health.","oneSentence":"Fecal Microbiota Transplantation involves transferring fecal matter from a healthy donor into a patient's gut to restore a balanced gut microbiome.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:24:11.076Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clostridioides difficile infection"},{"name":"Inflammatory bowel disease"},{"name":"Irritable bowel syndrome"}]},"trialDetails":[{"nctId":"NCT06478602","phase":"PHASE3","title":"Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis","status":"COMPLETED","sponsor":"Cristian Ichim","startDate":"2024-08-05","conditions":"Liver Cirrhosis","enrollment":19},{"nctId":"NCT07496502","phase":"PHASE1, PHASE2","title":"Effect of Oral Microbiota on MDRO Decolonization","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2022-03-31","conditions":"Clostridioides Difficile Infection, Drug Resistance, Bacterial, Gastrointestinal Microbiome","enrollment":42},{"nctId":"NCT06591013","phase":"NA","title":"Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Nationality in the Treatment of IBD","status":"COMPLETED","sponsor":"First Affiliated Hospital of Kunming Medical University","startDate":"2022-10-14","conditions":"Inflammatory Bowel Diseases","enrollment":80},{"nctId":"NCT04090346","phase":"PHASE4","title":"Fecal Microbiota Transplant","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2018-06-05","conditions":"Clostridium Difficile Infection","enrollment":24},{"nctId":"NCT06290258","phase":"PHASE1, PHASE2","title":"Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2024-03-06","conditions":"Autism Spectrum Disorder, Gastrointestinal Diseases, Healthy","enrollment":60},{"nctId":"NCT04038619","phase":"PHASE1","title":"Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-01","conditions":"Colitis, Diarrhea, Malignant Genitourinary System Neoplasm","enrollment":40},{"nctId":"NCT04975217","phase":"EARLY_PHASE1","title":"Fecal Microbial Transplants for the Treatment of Pancreatic Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-12-14","conditions":"Pancreatic Ductal Adenocarcinoma","enrollment":10},{"nctId":"NCT05998213","phase":"PHASE2","title":"Transfer of Feces in Ulcerative Colitis 2","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2020-06-12","conditions":"Ulcerative Colitis, Ulcerative Colitis Flare, Ulcerative Colitis Acute","enrollment":85},{"nctId":"NCT05174273","phase":"PHASE2, PHASE3","title":"Neurocognitive Effects of FMT in MDD Patients With and Without IBS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Valerie Taylor","startDate":"2022-04-06","conditions":"Major Depressive Disorder, Irritable Bowel Syndrome","enrollment":133},{"nctId":"NCT06071312","phase":"PHASE1, PHASE2","title":"FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-09-23","conditions":"Clostridium Difficile, Ulcerative Colitis","enrollment":64},{"nctId":"NCT07481422","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome","status":"RECRUITING","sponsor":"University of Rijeka","startDate":"2026-03-15","conditions":"Irritable Bowel Syndrome (IBS)","enrollment":70},{"nctId":"NCT07477782","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05","conditions":"Primary Sclerosing Cholangitis (PSC), Inflammatory Bowel Disease (IBD)","enrollment":72},{"nctId":"NCT07464392","phase":"NA","title":"FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis","status":"NOT_YET_RECRUITING","sponsor":"Changhai Hospital","startDate":"2026-03-01","conditions":"Acute Pancreatitis","enrollment":150},{"nctId":"NCT03819296","phase":"PHASE1","title":"Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-21","conditions":"Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8","enrollment":800},{"nctId":"NCT07463248","phase":"PHASE2","title":"PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy","status":"NOT_YET_RECRUITING","sponsor":"Wang Xin","startDate":"2026-03-05","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":64},{"nctId":"NCT05067595","phase":"PHASE1","title":"Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2025-01-24","conditions":"Intestinal Graft Versus Host Disease","enrollment":72},{"nctId":"NCT03786900","phase":"","title":"Fecal Microbiota Transplantation (FMT): PRIM-DJ2727","status":"AVAILABLE","sponsor":"Herbert DuPont, MD","startDate":"","conditions":"Recurrent Clostridium Difficile Infection, Multidrug-resistant Klebsiella Pneumoniae Urinary Tract Infection","enrollment":""},{"nctId":"NCT07458984","phase":"PHASE3","title":"FMT Capsules for rCDI","status":"NOT_YET_RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2026-02-25","conditions":"Clostridioides Difficile Infection Recurrence, FMT","enrollment":76},{"nctId":"NCT07454408","phase":"PHASE1, PHASE2","title":"Evaluation of the Outcome of Fecal Microbiota Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2026-03-07","conditions":"Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS","enrollment":40},{"nctId":"NCT07042438","phase":"PHASE2","title":"Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-02-11","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma","enrollment":56},{"nctId":"NCT06333795","phase":"NA","title":"Faecal Microbiota Transplantation Against Chronic Diarrhea in Patients With Systemic Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Aarhus","startDate":"2024-04-01","conditions":"Diarrhea, Systemic Sclerosis","enrollment":20},{"nctId":"NCT05917379","phase":"PHASE1, PHASE2","title":"The Efficacy and Safty of FMT in Patients With CID","status":"COMPLETED","sponsor":"Peking University Sixth Hospital","startDate":"2023-10-08","conditions":"Insomnia Chronic, Fecal Microbiota Transplantation, Sleep Disorder","enrollment":80},{"nctId":"NCT07432984","phase":"PHASE2","title":"Fecal Microbiota Transplant(FMT) Combination With Tislelizumab in Advanced or Metastatic NSCLC","status":"NOT_YET_RECRUITING","sponsor":"Se-Hoon Lee","startDate":"2026-04-30","conditions":"Non Small Cell Lung Cancer","enrollment":15},{"nctId":"NCT03562741","phase":"NA","title":"Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile","status":"RECRUITING","sponsor":"Krunal Patel","startDate":"2014-01-16","conditions":"Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection","enrollment":500},{"nctId":"NCT07421947","phase":"NA","title":"Effects of Fecal Microbiota Transplantation in Patients With Type 2 Diabetes and Coronary Artery Disease (CAD-Microbiome) - A Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"University of Zurich","startDate":"2026-04","conditions":"Coronary Artery Disease, Type 2 Diabetes Mellitus (T2DM)","enrollment":30},{"nctId":"NCT03524352","phase":"PHASE3","title":"the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nantes University Hospital","startDate":"2020-03-12","conditions":"Pouchitis","enrollment":42},{"nctId":"NCT05664113","phase":"PHASE1","title":"Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2025-07-07","conditions":"Gastro-Intestinal Disorder","enrollment":10},{"nctId":"NCT06603883","phase":"PHASE2, PHASE3","title":"Efficacy of Fecal Microbiota Transplantation in ICU Patients With Gastrointestinal Dysfunction-induced Enteral Nutrition Intolerance","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-10-19","conditions":"Gastrointestinal Dysfunction-induced Enteral Nutrition Intolerance","enrollment":60},{"nctId":"NCT07381374","phase":"NA","title":"Fecal Microbiota Transplantation in Children With ASD","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Children's Hospital","startDate":"2026-02-01","conditions":"Autism Spectrum Disorder","enrollment":75},{"nctId":"NCT07387952","phase":"NA","title":"The Safety and Efficacy of Fecal Microbiota Transplantation Combined With Nutritional Intervention in the Treatment of Functional Constipation：a Pilot Study","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-07-30","conditions":"Constipation - Functional, Fecal Microbiota Transplantation (FMT), Chronic Constipation","enrollment":5},{"nctId":"NCT03594487","phase":"PHASE1","title":"Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis","status":"TERMINATED","sponsor":"Jeffrey Gelfand","startDate":"2018-11-16","conditions":"Relapsing Remitting Multiple Sclerosis","enrollment":5},{"nctId":"NCT05327790","phase":"PHASE2","title":"LFMT vs Placebo in New Biologic Start for Ulcerative Colitis","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2022-06-03","conditions":"Ulcerative Colitis","enrollment":40},{"nctId":"NCT07374094","phase":"","title":"Clostridioides Difficile: Understanding Responses and Treatment Effects","status":"RECRUITING","sponsor":"Umeå University","startDate":"2026-01-26","conditions":"Clostridioides Difficile Infection","enrollment":200},{"nctId":"NCT07364617","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD","status":"NOT_YET_RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2026-02-01","conditions":"Graft vs Host Disease","enrollment":35},{"nctId":"NCT06649981","phase":"PHASE1","title":"Aging Resilience Through Microbiota Optimization and Regulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gonzalo Jorquera, PhD","startDate":"2025-01-10","conditions":"Resilience, Cognitive Function and Well-Being, Muscle Function, Handgrip Strength Test","enrollment":80},{"nctId":"NCT07345403","phase":"","title":"GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Analyses, and Pre- and Intraoperative Clinical Data - to Predict Early Complications After Cardiac Surgery.","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2026-01-01","conditions":"Postoperative Delirium (POD), Postoperative Bleeding, Acute Kidney Injury","enrollment":3000},{"nctId":"NCT03483246","phase":"PHASE3","title":"Impact of Fecal Microbiota Transplantation in Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-09-17","conditions":"Ulcerative Colitis","enrollment":150},{"nctId":"NCT07332260","phase":"PHASE1","title":"Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"University Hospital of North Norway","startDate":"2026-01","conditions":"Alzheimer s Disease, Faecal Microbiota Transplantation (FMT)","enrollment":10},{"nctId":"NCT06026371","phase":"PHASE2","title":"Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2023-12-12","conditions":"Acute Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm","enrollment":138},{"nctId":"NCT04444362","phase":"NA","title":"Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery (PANDA IV)","status":"ENROLLING_BY_INVITATION","sponsor":"Nanjing Medical University","startDate":"2025-01-01","conditions":"Cardiovascular Disease, Cardiopulmonary Bypass","enrollment":500},{"nctId":"NCT07319364","phase":"PHASE1","title":"A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":"Fecal Microbiota Transplantation (FMT), Gastrointestinal Neoplasms, Antineoplastic Agents","enrollment":90},{"nctId":"NCT05598112","phase":"EARLY_PHASE1","title":"Effect of Gut Microbiome Intervention on Aging Via Oral FMT","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2023-04-24","conditions":"Aging, Frailty","enrollment":210},{"nctId":"NCT03420482","phase":"PHASE2","title":"Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2018-04-01","conditions":"Hepatic Encephalopathy","enrollment":30},{"nctId":"NCT07247786","phase":"PHASE2","title":"Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT)","status":"NOT_YET_RECRUITING","sponsor":"Fundación GECP","startDate":"2026-03-15","conditions":"Non Small Cell Lung Cancer, Respiratory Tract Neoplasm","enrollment":68},{"nctId":"NCT04729322","phase":"PHASE2","title":"Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-22","conditions":"Metastatic Colorectal Adenocarcinoma, Metastatic Small Intestinal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8","enrollment":15},{"nctId":"NCT07292142","phase":"PHASE1, PHASE2","title":"FMT in Triple Negative Breast Cancer Guided by ctDNA","status":"NOT_YET_RECRUITING","sponsor":"Jewish General Hospital","startDate":"2026-02","conditions":"Breast Cancer","enrollment":125},{"nctId":"NCT06218602","phase":"PHASE2","title":"Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-02-19","conditions":"Lymphoma","enrollment":40},{"nctId":"NCT07276100","phase":"PHASE2","title":"Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2026-01-01","conditions":"Hepato Cellular Carcinoma (HCC)","enrollment":15},{"nctId":"NCT03829475","phase":"PHASE2","title":"ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2020-01-01","conditions":"Inflammatory Bowel Diseases, Clostridium Difficile Infection","enrollment":61},{"nctId":"NCT04924270","phase":"PHASE2","title":"Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases","status":"RECRUITING","sponsor":"Odense University Hospital","startDate":"2023-12-13","conditions":"Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis","enrollment":200},{"nctId":"NCT05533983","phase":"NA","title":"FMT With Nivolumab in Patients With Advanced Solid Cancers Who Have Progressed During Anti-PD-(L)1 Therapy","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2023-03-08","conditions":"Solid Carcinoma","enrollment":50},{"nctId":"NCT03819803","phase":"PHASE3","title":"Fecal Microbiota Transplantation in aGvHD After ASCT","status":"RECRUITING","sponsor":"Medical University of Graz","startDate":"2017-03-01","conditions":"Graft Versus Host Disease in GI Tract","enrollment":15},{"nctId":"NCT06692361","phase":"NA","title":"Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder","status":"RECRUITING","sponsor":"Gang Wang","startDate":"2025-01-01","conditions":"Major Depressive Disorder (MDD), Depression - Major Depressive Disorder","enrollment":214},{"nctId":"NCT02269150","phase":"PHASE2","title":"Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2014-10","conditions":"Allogeneic Hematopoietic Stem Cell","enrollment":59},{"nctId":"NCT06206707","phase":"NA","title":"FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2024-01-23","conditions":"Diarrhea, Colitis, Malignant Melanoma","enrollment":20},{"nctId":"NCT05911997","phase":"PHASE1","title":"MTC Versus FMT in for RCDI","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2024-01-08","conditions":"Clostridiodies Difficile Infections","enrollment":60},{"nctId":"NCT06321536","phase":"PHASE2","title":"Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-01-13","conditions":"Multi-Drug Resistant Organism Colonization","enrollment":60},{"nctId":"NCT04883762","phase":"PHASE1","title":"Stool Transplant to Control Treatment-related Diarrhea","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-05-10","conditions":"Fecal Microbiota Transplantation (FMT)","enrollment":4},{"nctId":"NCT07190183","phase":"","title":"Washed Microbiota Transplantation for Food Intolerance","status":"RECRUITING","sponsor":"The Second Hospital of Nanjing Medical University","startDate":"2025-01-01","conditions":"Food Intolerance","enrollment":100},{"nctId":"NCT04630847","phase":"PHASE1","title":"Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders","status":"NOT_YET_RECRUITING","sponsor":"ProgenaBiome","startDate":"2025-12","conditions":"Autism, Autism Spectrum Disorder","enrollment":10},{"nctId":"NCT04163289","phase":"PHASE1","title":"Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2020-01-23","conditions":"Renal Cell Carcinoma","enrollment":20},{"nctId":"NCT07154784","phase":"PHASE2, PHASE3","title":"Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis","status":"ENROLLING_BY_INVITATION","sponsor":"Seoul National University Hospital","startDate":"2023-07-19","conditions":"Ulcerative Colitis, Fecal Microbiota Transplantation","enrollment":30},{"nctId":"NCT05753774","phase":"NA","title":"Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders","status":"RECRUITING","sponsor":"Biao Zou","startDate":"2022-08-01","conditions":"Functional Gastrointestinal Disorders","enrollment":100},{"nctId":"NCT06376331","phase":"PHASE1","title":"Washed Microbiota Transplantation for Attention-deficit/Hyperactivity Disorder","status":"RECRUITING","sponsor":"The Second Hospital of Nanjing Medical University","startDate":"2024-04-28","conditions":"Attention-deficit/Hyperactivity Disorder","enrollment":50},{"nctId":"NCT06030752","phase":"PHASE1","title":"WMT for Autism Spectrum Disorder (ASD)","status":"RECRUITING","sponsor":"The Second Hospital of Nanjing Medical University","startDate":"2023-09-20","conditions":"Autism Spectrum Disorder","enrollment":80},{"nctId":"NCT06673134","phase":"","title":"Prospective Cohort Establishment and Clinical Observation of Children With Crohn's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tongji Hospital","startDate":"2023-12-01","conditions":"Crohn Disease","enrollment":100},{"nctId":"NCT07094984","phase":"NA","title":"Comparison of Three Interventions for Antibiotic-Resistant Bacteria (ARB) Decolonization From the Gastrointestinal Tract","status":"RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2024-12-31","conditions":"Drug Resistance, Bacterial, Antimicrobial Drug Resistance","enrollment":360},{"nctId":"NCT06022406","phase":"PHASE2","title":"Fecal Microbiota Translantation (FMT) to Reduce Inflammation in PLWH: The Gutsy Pilot Study","status":"COMPLETED","sponsor":"Jean-Pierre Routy","startDate":"2024-07-31","conditions":"HIV-1-infection","enrollment":20},{"nctId":"NCT07149441","phase":"NA","title":"Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai 10th People's Hospital","startDate":"2025-08-01","conditions":"Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis), Fecal Microbiota Transplantation","enrollment":94},{"nctId":"NCT05967871","phase":"PHASE1","title":"Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial Overgrowth","status":"RECRUITING","sponsor":"McMaster Children's Hospital","startDate":"2024-03-11","conditions":"Small Intestinal Bacterial Overgrowth","enrollment":20},{"nctId":"NCT06744751","phase":"NA","title":"A Study on the Effects of Combined FMT on Gut Microbiota and Eating Disorder Symptoms in AN","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2025-09-01","conditions":"Anorexia Nervosa","enrollment":30},{"nctId":"NCT07120490","phase":"NA","title":"STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2025-10","conditions":"Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence, Fecal Microbiota Transplantation (FMT)","enrollment":424},{"nctId":"NCT02127398","phase":"PHASE2","title":"Stool Transplants to Treat Refractory Clostridium Difficile Colitis","status":"RECRUITING","sponsor":"Duke University","startDate":"2016-04","conditions":"Clostridium Difficile Colitis","enrollment":77},{"nctId":"NCT04997733","phase":"PHASE3","title":"Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-09-22","conditions":"Crohn Disease","enrollment":150},{"nctId":"NCT05690048","phase":"PHASE2","title":"Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)","status":"RECRUITING","sponsor":"Michael Dill","startDate":"2025-07-16","conditions":"Immunotherapy, HCC - Hepatocellular Carcinoma","enrollment":48},{"nctId":"NCT03948919","phase":"PHASE1","title":"Fecal Transplant for Ulcerative Colitis","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2019-07-31","conditions":"Ulcerative Colitis","enrollment":26},{"nctId":"NCT05829109","phase":"EARLY_PHASE1","title":"Fecal Microbiota Transplant for Patients With Chronic Pouchitis","status":"RECRUITING","sponsor":"Maia Kayal","startDate":"2024-09-01","conditions":"Chronic Pouchitis, Pouchitis","enrollment":16},{"nctId":"NCT06447220","phase":"","title":"Washed Microbiota Transplantation for Malnutrition","status":"RECRUITING","sponsor":"The Second Hospital of Nanjing Medical University","startDate":"2023-12-17","conditions":"Malnutrition","enrollment":100},{"nctId":"NCT06083142","phase":"EARLY_PHASE1","title":"Fecal Microbiota Transplant for Autobrewery Syndrome","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-02-14","conditions":"Auto-Brewery Syndrome, Gut Fermentation Syndrome","enrollment":8},{"nctId":"NCT05286294","phase":"PHASE2","title":"Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oslo University Hospital","startDate":"2022-06-28","conditions":"Melanoma Stage IV, Head and Neck Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma","enrollment":20},{"nctId":"NCT06433180","phase":"PHASE3","title":"Study of Fecal Microbiota Transplantation (FMT) in Severe IBS Patients","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-07-01","conditions":"Irritable Bowel Syndrome","enrollment":150},{"nctId":"NCT06647277","phase":"PHASE1","title":"Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease","status":"NOT_YET_RECRUITING","sponsor":"ProgenaBiome","startDate":"2026-07","conditions":"Parkinson Disease","enrollment":10},{"nctId":"NCT04583098","phase":"","title":"The Effect of Fecal Microbiota Transplantation on the Decolonization of Multidrug-resistant Organisms","status":"COMPLETED","sponsor":"Chuncheon Sacred Heart Hospital","startDate":"2019-03-14","conditions":"Carbapenem-Resistant Enterobacteriaceae Infection, Vancomycin-Resistant Enterococcal Infection","enrollment":100},{"nctId":"NCT06001333","phase":"NA","title":"Efficacy and Safety of FMT for the Decolonization of MDROs in the Intestinal Tract","status":"RECRUITING","sponsor":"Chuncheon Sacred Heart Hospital","startDate":"2023-09-18","conditions":"Carbapenem-Resistant Enterobacteriaceae, Vancomycin (Glycopeptide) Resistant Enterococcus (VRE)","enrollment":240},{"nctId":"NCT06346093","phase":"NA","title":"Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer","status":"RECRUITING","sponsor":"Changhai Hospital","startDate":"2024-04-02","conditions":"Advanced Gastric Cancer","enrollment":124},{"nctId":"NCT04878718","phase":"","title":"Vancomycin and Fecal Microbiota Transplant in a Single Patient With Autism Spectrum Disorder","status":"NO_LONGER_AVAILABLE","sponsor":"ProgenaBiome","startDate":"","conditions":"Autism Spectrum Disorder, Autism","enrollment":""},{"nctId":"NCT06687382","phase":"PHASE2","title":"Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis","status":"RECRUITING","sponsor":"Mikrobiomik Healthcare Company S.L.","startDate":"2025-04-03","conditions":"Diverticulitis, Diverticulitis of Sigmoid","enrollment":81},{"nctId":"NCT07003438","phase":"EARLY_PHASE1","title":"Study on the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Steroid - Dependent /Steroid-resistant Nephrotic Syndrome in Children","status":"NOT_YET_RECRUITING","sponsor":"Zhang Ting","startDate":"2025-06-01","conditions":"Steroid-Resistant Nephrotic Syndrome, Steroid-Dependent Nephrotic Syndrome","enrollment":120},{"nctId":"NCT05373784","phase":"EARLY_PHASE1","title":"FMT in Uncomplicated Diverticulitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Justin Maykel","startDate":"2024-03-15","conditions":"Diverticulitis, Uncomplicated Diverticular Disease","enrollment":10},{"nctId":"NCT06992453","phase":"NA","title":"Multi-omics Dissection of Gut Microbiome Engraftment During FMT","status":"NOT_YET_RECRUITING","sponsor":"Catholic University of the Sacred Heart","startDate":"2025-06-01","conditions":"Recurrent C. Difficile (rCDI), Ulcerative Colitis (UC), Metabolic Syndrome (MetS)","enrollment":90},{"nctId":"NCT05035342","phase":"PHASE3","title":"Fecal Transplantation to Eradicate Colonizing Emergent Superbugs","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-01-11","conditions":"Enterobacteriaceae Infections, Fecal Microbiota Transplantation","enrollment":214},{"nctId":"NCT05548452","phase":"PHASE1, PHASE2","title":"Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease","status":"RECRUITING","sponsor":"Virginia Commonwealth University","startDate":"2022-11-21","conditions":"Liver Disease; Alcohol-Related, Cirrhosis, Alcohol Use Disorder","enrollment":80},{"nctId":"NCT06960122","phase":"NA","title":"Clinical Study on Fecal Microbiota Transplantation for Diarrhea After Total Pancreatectomy","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-05-01","conditions":"Pancreatic Cancer, Resected, Diarrhea","enrollment":10},{"nctId":"NCT05204641","phase":"PHASE2","title":"Effect of Fecal Microbiota Transfer on Progression of Parkinson Disease","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2022-01-04","conditions":"Parkinson Disease","enrollment":59},{"nctId":"NCT04182633","phase":"PHASE2","title":"MTT for Children With ASD Who Have Gastrointestinal Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arizona State University","startDate":"2019-11-15","conditions":"Autism Spectrum Disorder, Gastro-Intestinal Disorder, Constipation","enrollment":50},{"nctId":"NCT06938165","phase":"NA","title":"The Safety and Efficacy of Fecal Microbiota Transplant (FMT) for Steroid-refractory Graft-versus-host Disease","status":"COMPLETED","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2020-04-27","conditions":"GVHD","enrollment":46},{"nctId":"NCT06931808","phase":"PHASE4","title":"Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer","status":"ENROLLING_BY_INVITATION","sponsor":"First Affiliated Hospital of Ningbo University","startDate":"2025-03-01","conditions":"Localized Advanced Rectal Adenocarcinoma","enrollment":20},{"nctId":"NCT05321758","phase":"NA","title":"Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2020-03-22","conditions":"Crohn Disease","enrollment":50},{"nctId":"NCT06924645","phase":"NA","title":"Fecal Microbiota Transplantation for Preventing Gastrointestinal Symptoms in Extrapulmonary Neuroendocrine Neoplasms: A Real-World Study","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-05-01","conditions":"Treatment-related Gastrointestinal Toxicity (Including Diarrhea, Constipation, Nausea, and Vomiting), Extrapulmonary Neuroendocrine Neoplasms","enrollment":40},{"nctId":"NCT06920212","phase":"NA","title":"Clinical Safety and Efficacy of Fecal Microbiota Transplantation (FMT) in the Treatment of Alzheimer's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai 10th People's Hospital","startDate":"2024-10-01","conditions":"Fecal Microbiota Transplantation","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1677,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Biological: Fecal Microbiota Transplantation","genericName":"Biological: Fecal Microbiota Transplantation","companyName":"Fundación GECP","companyId":"fundaci-n-gecp","modality":"Biologic","firstApprovalDate":"","aiSummary":"Fecal Microbiota Transplantation involves transferring fecal matter from a healthy donor into a patient's gut to restore a balanced gut microbiome. Used for Clostridioides difficile infection, Inflammatory bowel disease, Irritable bowel syndrome.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}